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Abstract
Background: Following the emergence of the influenza A(H1N1)2009 virus, the French ministry of health decided
to offer free vaccination against pandemic influenza to the entire French population. Groups of people were
defined and prioritised for vaccination.
Methods: We took a random sample of the population of mainland France and conducted a retrospective cross-
sectional telephone survey to estimate vaccination coverage against seasonal and pandemic influenza and to
identify determinants of these vaccinations.
Results: 10,091 people were included in the survey. Overall seasonal influenza vaccination coverage (IVC) remained
stable in the population from the 2008-2009 season to the 2009-2010 season reaching 20.6% and 20.8%
respectively. Overall pandemic IVC in the French population is estimated to be 11.1% (CI95%: 9.8 - 12.4). The
highest pandemic IVC was observed in the 0-4 years age group. For individuals with health conditions associated
with higher risk of influenza, pandemic IVC was estimated to be 12.2% (CI95%: 9.8 - 15.1). The main determinants
associated with pandemic influenza vaccine uptake were: living in a household with a child < 5 years ORadj: 2.0
(CI95%: 1.3 - 3.1) or with two children < 5 years or more, ORadj: 2.7 (CI95%: 1.4 - 5.1), living in a household where
the head of the family is university graduate (>2 years), ORadj: 2.5 (CI95%: 1.5 - 4.1), or has a higher professional and
managerial occupation, ORadj: 3.0 (CI95%: 1.5 - 5.5) and being vaccinated against seasonal influenza, ORadj: 7.1
(CI95%: 5.1 - 10.0). Being an individual with higher risk for influenza was not a determinant for pandemic influenza
vaccine uptake. These determinants are not the same as those for seasonal influenza vaccination.
Conclusions: Overall A(H1N1)2009 influenza vaccine uptake remained low, particularly among individuals with
higher risk for influenza and was lower than that observed for seasonal influenza. The reasons behind people’s
reluctance to be vaccinated need to be investigated further.
Background
Influenza virus infection is a major public health pro-
blem, as shown by its high morbidity and mortality. On
11 June 2009, the outbreak of the influenza A(H1N1)
virus was declared a pandemic by the World Health
Organization [1]. The first case of A(H1N1)2009 in
France was reported on 1 May 2009 [2]. In the weeks
that followed, an increase in cases was observed and the
containment phase was declared over on 6 July 2009 [3].
The virus spread through mainland France during the
summer, and the pandemic wave lasted from late Octo-
ber to late December 2009 [4].
Currently, the French recommendations for yearly sea-
sonal influenza include vaccination of all people over 64
years, people with specific underlying diseases, and the
professionals who are in contact with them, including
health care workers (HCW).
These recommendations were maintained for the
2009-2010 season because co-circulation of seasonal
viruses with A(H1N1)2009 virus could not be excluded.
In France, seasonal influenza vaccination is provided
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groups. Each year, they receive a voucher for free-of-
charge seasonal vaccination from the national health
insurance fund.
In 2009, the ministry of health offered free pandemic
influenza vaccination to the entire French population.
Priority groups for vaccination were defined and ranked
(Table 1) [5]. Individuals were identified by the National
Health Insurance fund and a voucher for free vaccina-
tion was sent to the different groups one by one. This
decision was made because the vaccine was not immedi-
ately available for the entire population. The vaccination
campaign for health care workers began in late October,
and the campaign for the rest of the population in mid-
November. A(H1N1) pandemic vaccination was carried
out in special vaccination centres specifically set-up for
logistic reasons, and in order to avoid overloading gen-
eral practitioners and paediatricians in case of high
demand for care for A(H1N1)2009 patients.
Before the start of the pandemic, the French Institute
for Public Health Surveillance (InVS) organized a popu-
lation-level telephone survey that would estimate the
population prevalence of gastrointestinal illness and self-
defined influenza between May 2009 and April 2010.
The telephone survey would also estimate seasonal
influenza vaccination coverage and identify determinants
of vaccination uptake. In the context of the pandemic,
the questionnaire was adapted to obtain real-time esti-
mates of influenza vaccination coverage for both seaso-
nal and pandemic influenza and also to identify possible
determinants of pandemic influenza vaccine uptake.
This article presents the results relating to influenza
vaccination coverage (IVC) and the determinants of vac-
cination uptake.
Methods
The retrospective cross-sectional telephone survey was
carried out between May 2009 and April 2010 among a
random sample of the French mainland population (the
French overseas territories are not included in this
study).
Study population and sample
The study population included all people living in resi-
dential households in mainland France who were con-
nected to a land telephone line and who spoke French.
Households and household members were randomly
selected for interview. At the first level, the sampling
frame was the French mainland telephone directory
stratified by region and town size. Each month a list of
around 2750 numbers was selected randomly from the
French telephone directory. Each number was then
incremented by one, in order to generate a list including
also unlisted telephone numbers. This new list replaced
the first one.
At the second level, the sampling frame was the resi-
dents of the selected household. Persons were stratified
by age (< 5 years, ≥ 5 years), and one child < 5 years (if
any), and one person ≥ 5 years were randomly selected
among the family members by taking the person who
had the next birthday. If the selected child was < 18
years and ≥ 12 years old, a parent could choose to
answer for the child or allow the child to answer. If the
child was < 12 years old, one parent was asked to
answer for him.
In order to reduce refusals, a letter introducing the
survey was sent by post before the interview to the
households listed in the telephone directory. Interviews
w e r ec o n d u c t e df r o m4p mt o9p mf r o mM o n d a yt o
Friday and from 10 am to 2 pm on Saturdays, during
two weeks each month. As many as 7 rings per call and
20 calls were made to each sampled phone number. If
the selected person was not available, a telephone
appointment was offered. All non-residential house-
holds, such as offices, institutions or holiday homes,
were excluded from the study. Each month approxi-
mately 840 individuals were included.
All interviews were conducted by professional inter-
viewers, using Computer Assisted Telephone Interviews
(CATI). The interviewers were monitored by supervisors
to assess adherence to surveying standards. The inter-
viewers-to-supervisor ratio was 6:1. Daily quality con-
trols were performed by supervisors.
The sample size of 800 questionnaires per month was
calculated to obtain accurate estimates for incidence of
gastrointestinal illness and of self-defined influenza,
which were the main outcomes of the survey. Concern-
ing influenza vaccination coverage, this sample size
allowed a precision of 5% for an overall IVC of 50%,
with an a error of 5% and a conservative hypothesis of
a design effect of 2.
Data collection
Verbal consent was obtained. If a child was selected,
consent for participation in the study was requested
from a parent (or legal guardian). If the selected resident
Table 1 Priority groups for pandemic vaccination.
Adapted from [5]
Groups Priority
Health care workers and emergency service personnel in
contact with influenza cases or at-risk individuals for influenza,
pregnant women, infants aged 6-23 months at risk of
influenza complications, household contacts and caregivers for
infant younger than 6 months of age
1
Individuals aged 2-64 years at risk of influenza complications 2
Infants aged 6-23 months without risk factors for influenza,
individuals > 64 years at risk of influenza complications
3
Individuals aged 2-18 years without risk factors for influenza 4
Individuals > 18 years without risk factors for influenza 5
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possible reasons of refusal.
The questionnaire was pilot-tested for clarity and
length with 169 interviews in March-April 2009.
Questions were related to seasonal influenza vaccina-
tion uptake during the 2008-2009 season and during the
2009-2010 season according to the date of the interview
(before or after September 2009); to whether or not
individuals were likely to be vaccinated free of charge
for seasonal vaccination, receipt of a personal voucher
from the national health insurance fund; to pandemic
influenza vaccination uptake and to whether or not the
r e s p o n d e n th a dr e c e i v e dapersonal voucher from the
national health insurance to be vaccinated for pandemic
influenza at the time of the survey.
The gender and age of each respondent were collected,
as well as socio-demographic characteristics of the
household: household size and age of persons living in
the household, education level and occupation of the
head of the family. Adults were asked whether they were
healthcare workers. Women were asked whether they
were pregnant (question introduced in December 2009).
According to national regulations, ethical approval was
not required for this observational retrospective study
[6]. However, a verbal consent was obtained for the
interview and all data transmitted to InVS were
anonymous.
Analysis
The main outcomes were seasonal and pandemic IVC.
Seasonal IVC for the 2008-2009 season was estimated
from interviews carried out between May and August
2009. Seasonal and pandemic IVC for the 2009-2010
season were estimated from interviews carried out from
January 2010 onwards when monthly IVC reached a pla-
teau (Figure 1). An at-risk individual of seasonal influ-
enza was defined as a person who reported having
received a personal voucher for free seasonal vaccination
from the national health insurance fund. All estimates
took into account the sampling design components (pri-
mary sampling unit, sampling weights) in all calculations
(descriptive analyses, confidence intervals, logistic
regressions). For each respondent, sampling weights
were adjusted by age, gender, region and town size. For
health care workers, the analysis took into account peo-
ple aged 20-64 years. Possible determinants of seasonal
and pandemic influenza vaccination uptake were investi-
gated using univariate and multivariate logistic regres-
sion. Explanatory variables tested were: age, gender,
number of children < 5 years and number of persons in
Figure 1 Monthly estimates of influenza vaccination coverage (CI95%) for seasonal and pandemic influenza from September 2009 to
April 2010.
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region of residence, educational level and occupation of
the head of the family, access to free vaccination for sea-
sonal influenza and the seasonal influenza vaccine
uptake for pandemic vaccination. All exposures where
the association showed a p value < 0.2 in the univariate
analysis were included and forced in the multivariate
model. A two-sided p value < 0.05 was considered to be
statistically significant. Odds ratios, adjusted odds ratios
and 95% confidence intervals (95% CI) are presented for
the main findings. Only statistically significant variables
in the univariate analysis (p < 0.2) are listed.
We tested additional interaction effects (age groups
and gender, at-risk individual and gender) with a two-
sided p value < 0.05 considered to be statistically signifi-
cant. Collinearity between variables was tested. Data
analyses were performed using Stata 9.2
® (StataCorp,
Texas, USA).
Results
Participation
Of the 32,676 phone numbers selected, contact was
established with 17,036 but 1,053 phone numbers were
excluded because they did not correspond to a residen-
tial household. Among the 15,983 households eligible
for the survey, 8,905 accepted to participate (response
rate: 55.7%). Reasons given for refusals were (more than
one response possible): lack of time (42%), not inter-
ested in the survey (42%), never take part in interviews
(21%). A total of 10,130 people were randomly selected,
of which 10,091 were included in the survey.
Seasonal and pandemic influenza vaccination coverage
The estimated IVC for the 2008-09 season is based on
the 3,399 interviews made from April to August 2009,
while the estimates for seasonal and pandemic IVC for
the 2009-2010 season are based on the 3,264 interviews
made from January to April 2010.
Overall seasonal IVC remained stable within the
population from the 2008-2009 season to the 2009-2010
season, reaching 20.6% and 20.8% respectively (Table 2).
Analysis by age groups did not show any statistical dif-
ferences between the two seasons. The highest seasonal
IVC was observed among adults older than 64 years.
Among at-risk individuals, the overall seasonal IVC was
estimated at 54.9% in 2008-2009 and remained stable in
the following season (54.5%). Analysis by age groups did
not show any differences, but confidence intervals were
large. Seasonal IVC for HCW showed an increasing
trend, with 33.9% in 2009-10 compared with 24.9% (N =
133 interviews) in 2008-2009, but this difference is not
statistically significant.
Overall pandemic IVC in the French population was
11.1% (CI95%: 9.8 - 12.4). The pandemic IVC in the 0-4
years age group was significantly higher than the seasonal
IVC in the same age group (17.6% vs. 4.9%). The estimate
of pandemic IVC for children younger than 3 years was
19.2% (CI95%: 14.3 - 25.2). Pandemic IVC in those older
than 64 years was 10.4% (CI95%: 8.0 - 13.6), significantly
lower than the seasonal IVC in this age group (63%). For
at risk individuals, overall pandemic IVC was estimated at
12.2% (CI95%: 9.8 - 15.1) and IVC for those younger than
65 years at 16.3% (11.4 - 22.8). Both were significantly
lower than the IVC estimated for seasonal influenza.
For HCW, pandemic and seasonal IVC were compar-
able for the 2009-2010 season (29.8% and 33.9% respec-
tively). For pregnant women, who were not targeted for
seasonal influenza vaccination, pandemic IVC was low,
at 12.8% (CI95%: 5.7 - 26.1).
The proportion of people who reported having
received a personal voucher for free pandemic influenza
vaccination increased with time. These proportions
were: 13.3% (CI95%: 10.8 - 16.3) in November 2009,
33.2% (CI95%: 29.6 - 37.0) in December 2009, 67.4%
(CI95%: 63.8 - 70.8) in January 2010, and 86.3% (CI95%:
83.6 - 88.6) in February, and remained relatively stable
during following months. Analysis by age group showed
that in January 2010, when the pandemic wave was over
in mainland France, receipt of these vouchers was esti-
mated at 83.2% (CI95%: 74.8 - 89.2) for the 0-4 years
age group, 69.2% (CI95%:59.0 - 77.8) for the 15-29 years
age group and 47.3% (CI95%: 38.6 - 56.2) for adults
older than 64 years.
Determinants of influenza vaccination coverage
Analyses of determinants were based on interviews
made from January to April 2010. For seasonal IVC,
multivariate analyses showed that being an at-risk indi-
vidual for influenza, being a HCW, living in a household
w h e r et h eh e a do ft h ef a m i l yw a sr e t i r e do rl i v i n gi na n
urban area were predictive of a greater vaccination
uptake (Table 3). Being younger than 30 years old and
living in a household where the head of family was uni-
versity graduated were predictive of a lower seasonal
vaccination uptake. The number of persons in the
household, the number of children < 5 years and the
gender were not significantly associated with seasonal
vaccination uptake.
For pandemic IVC, the following factors were predic-
tive of greater vaccination uptake after multivariate ana-
lyses: belonging to the 0-4 years age-group, to the 30-64
years age-group, living in a household with one or more
children aged < 5 years, with 2 or more persons, where
the head of the family is university graduated (>2 years),
or where the head of the household was a farmer, has a
higher professional and managerial occupation, has an
intermediate occupation or was retired (compared with
being a manual worker).
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out children younger than 5 years old, the size of the
household remained a determinant to increase vaccina-
tion uptake: 3 persons in the household, ORadj:2 . 2
(CI95%: 1.3 - 3.9, p = 0.006); 4 persons or more in the
household, ORadj: 2.6 (CI95%: 1.4 - 4.7, p = 0.003).
People vaccinated against seasonal influenza were
more likely to be vaccinated against pandemic influenza
(ORadj: 7.1 (5.1 - 10.0), p < 0.001).
No significant association was found between the pan-
demic vaccination coverage and being a subject at risk of
influenza complications, the town size or gender.
Discussion
Overall A(H1N1)2009 pandemic influenza vaccine
uptake was low at 11.1% (CI95%: 9.8 - 12.4). The main
result of the study is the observed low influenza vaccine
uptake of 16.3%(95% CI 11.4-22.8) among individuals less
than 65 years old who are at-risk for complications due
to influenza infection. This IVC is considerably lower
than the seasonal IVC in this same group (35.5%). Con-
trary to seasonal IVC, being at-risk for influenza was not
associated with higher pandemic vaccine uptake.
In France, 93% of A(H1N1)2009 influenza severe cases
were younger than 65 years, and 53% had an underlying
Table 2 Estimates of IVC for seasonal influenza (2008-2009 and 2009-2010 seasons) and pandemic influenza (2009-
2010 season)
Seasonal influenza A(H1N1)2009 influenza
2008-2009 season 2009-2010 season 2009-2010 season
N* IVC
(95% CI)
N* IVC
(95% CI)
N* IVC
(95% CI)
Age group
0 - 4 years 395 9.9
(6.8 - 14.2)
410 4.9
(2.9 - 8.0)
407 17.6
(14.1 - 21.8)
5 - 14 years 345 6.5
(4.0 - 10.3)
371 7.0
(4.5 - 10.6)
371 12.7
(9.4 - 17.0)
15 - 29 years 423 8.9
(6.1 - 12.8)
371 8.1
(5.4 - 12.1)
371 6.6
(4.2 - 10.2)
30 - 64 years 1,506 15.9
(14.1 - 17.9)
1,555 17.3
(15.4 - 19.5)
1,555 11.7
(10.0 - 13.6)
Older than 64 years 730 62.7
(58.9 - 66.4)
557 62.6
(58.1 - 66.9)
557 10.4
(8.0 - 13.6)
All age groups 3,399 20.6
(19.2 - 22.1)
3,264 20.8
(19.3 - 22.4)
3,261 11.1
(9.8 - 12.4)
Healthcare workers 133 24.9
(17.9 - 33.5)
120 33.9
(25.4 - 43.6)
120 29.8
(21.7 - 39.4)
Gender
Male 1,522 21.5
(19.3 - 23.9)
1,449 19.2
(17.0 - 21.6)
1,449 9.2
(7.9 - 10.2)
Female 1,877 19.8
(18.0 - 21.7)
1,815 22.3
(20.3 - 24.5)
1,812 7.8
(6.7 - 9.1)
At-risk individuals
0 - 4 years 22 31.7
(13.4 - 58.2)
32 18.6
(7.6 - 38.8)
32 25.3
(11.6 - 46.5)
5 - 14 years 14 13.1
(4.0 - 35.4)
27 31.5
(15.1 - 58.9)
27 21.5
(8.3 - 45.6)
15 - 29 years 23 21.8
(7.4 - 49.2)
20 24.3
(6.7 - 51.1)
20 0
(-)
30 - 64 years 133 40.3
(31.7 - 50.0)
150 41.1
(32.5 - 50.3)
150 17.9
(12.2 - 25.6)
Older than 64 years 730 62.7
(58.9 - 66.4)
557 62.6
(58.1 - 67.0)
557 10.4
(7.9 - 13.6)
All age groups 922 54.9
(51.2 - 58.6)
786 54.5
(50.6 - 58.4)
786 12.2
(9.8 - 15.1)
Younger than 65 years 192 33.6
(26.2 - 42.0)
229 35.5
(28.0 - 43.8)
229 16.3
(11.4 - 22.8)
Pregnant women - - 71 5.4
(1.8 - 15.4)
71 12.8
(5.7 - 26.1)
*N: number of respondents.
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Seasonal influenza vaccination Pandemic influenza vaccination
Odd ratio (95% CI) Odd ratio (95% CI)
Unadjusted
univariate
Adjusted
multi-
variate
p-value Unadjusted
univariate
Adjusted
multi-
variate
p-value
Age group
(Ref. Older than 64 years)
0 - 4 years 0.03
(0.02-0.05)
0.3
(0.1-0.6)
< 0.001 1.8
(1.2-2.7)
2.1
(1.0-4.5)
0.04
5 - 14 years 0.04
(0.03-0.07)
0.3
(0.2-0.6)
0.001 1.2
(0.8-2.0)
2.2
(1.0-4.8)
ns (0.05)
15 - 29 years 0.05
(0.03-0.09)
0.4
(0.2-0.8)
0.005 0.6
(0.3-1.1)
1.3
(0.5-3.0)
Ns
30 - 64 years 0.13
(0.1-0.2)
0.8
(0.5-1.2)
0.25 1.1
(0.8-1.6)
2.0
(1.0-3.8)
0.04
Number of children (< 5 years)
in the household (ref. None)
One child 0.2
(0.2-0.4)
0.8
(0.5 - 1.3)
ns 2.0
(1.4-2.9)
2.0
(1.3-3.1)
0.003
Two children or more 0.3
(0.1-0.6)
0.8
(0.3 - 1.7)
ns 2.5
(1.4-4.4)
2.7
(1.4-5.1)
0.004
Number of persons in the household
(ref: 1 person)
2 persons 0.8
(0.7-1.0)
0.9
(0.7 - 1.2)
ns 1.5
(1.0-2,1)
1.5
(1.0-2.2)
Ns
3 persons 0.23
(0.2-0.3)
0.8
(0.5 - 1.1)
ns 2.0
(1.3-3.1)
3.5
(1.5-4.1)
< 0.001
4 persons or more 0.2
(0.2-0.3)
0.8
(0.5 - 1.2)
ns 2.2
(1.5-3.2)
3.5
(1.4-4.3)
0.001
Gender
(Ref. female)
0.8
(0.7-1.0)
1.1
(0.9 - 1.4)
ns 1.2
(0.9-1.5)
1.1
(0.8-1.4)
Ns
Education level of the head of the family
(ref. primary level of education)
Less than high school 0.3
(0.2-0.4)
0.7
(0.5 - 1.0)
ns 1.0
(0.7-1.5)
1.3
(0.8-2.0)
Ns
High school graduate 0.3
(0.2 - 0.4)
0.7
(0.5 - 1.1)
ns 0.8
(0.4-1.3)
0.8
(0.4-1.4)
Ns
University graduate (2 years) 0.1
(0.1-0.2)
0.4
(0.2 - 0.7)
< 0.001 1.3
(0.8-2.2)
1.5
(0.9-2.7)
Ns
University graduate (>2 years) 0.3
(0.2-0.4)
0.9
(0.6 - 1.3)
ns 3.0
(2.0-4.4)
2.5
(1.5-4.1)
< 0.001
At-risk individual
(Ref. not to be an at-risk individual
All age groups included 9.9
(7.7-12.2)
4.0
(2.6-6.0)
< 0.001 1.5
(1.0-2.3)
1.2
(0.7-2.0)
Ns
At-risk individual younger than 65 years
old
4.5
(3.1-6.6)
4.0
(2.6-6.1)
< 0.001 1.6
(1.0-2.5)
1.2
(0.7-2.0)
Ns
Healthcare worker* 4.2
(2.6-6.5)
4.9
(2.9-8.1)
< 0.001 4.4
(2.7-7.1)
3.0
(1.8-5.0)
0.001
Occupation of the head of the family
(Ref. manual worker)
Farmer 0.6
(0.2-1.6)
0.7
(0.3-1.7)
ns 2.0
(0.8-5.4)
3.0
(1.1-8.0)
0.03
Self employed 1.4
(0.8-2.5)
1.5
(0.8-2.6)
ns 2.3
(1.2-4.5)
1.9
(0.9-3.8)
Ns
Higher professional and managerial
occupation
0.9
(0.5-1.4)
0.9
(0.5-1.5)
ns 3.9
(2.4-6.2)
3.0
(1.5 - 5.5)
0.001
Intermediate occupation 1.0
(0.6-1.6)
1.1
(0.6-1.9)
ns 2.2
(1.3-3.8)
2.0
(1.0-3.8)
0.04
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[7].
Early in the pandemic, pregnancy was considered to
be a risk factor for A(H1N1)2009 influenza complica-
tions [8], and therefore pregnant women were included
in the first priority group to be invited for pandemic
vaccination. Although public health experts strongly
recommended vaccination for pregnant women, pan-
demic IVC remained low in this population (12.8%).
This was despite the results of a survey conducted in
November 2009, that found that 37.9% of pregnant
women and 34.8% of at-risk individuals for influenza
complications intended to be vaccinated against pan-
demic influenza, i.e. a much higher figure than the IVC
actually estimated through our survey [9].
The highest pandemic IVC was observed among chil-
dren younger than 5 years old, who were one of the first
groups to be invited for pandemic vaccination. An
increased pandemic influenza uptake was associated
with the number of children younger than 5 years old in
the household and with the number of persons in the
household. These determinants are not found for seaso-
nal influenza. This suggests that compliance with the
pandemic vaccination campaign was higher in families
with children.
Low pandemic vaccine uptake (10.4%) was observed in
persons older than 64 years, which is much lower than
the seasonal vaccine uptake (62.6%). Adults older than
64 years old without risk factors for influenza were the
last group to receive their voucher in January 2010,
when the epidemic wave was over in mainland France.
As a consequence, less than half of the people in this
age group reported having received the pandemic vacci-
nation voucher in January. Fortunately, elderly people
were relatively unaffected by the pandemic, presumably
because of cross-protective antibodies [10]. A personal
voucher for free seasonal vaccination was sent to all per-
sons older than 64 years, making it impossible to distin-
guish people with underlying diseases for this age group
in our survey.
WHO recommended that “All countries should
immunize their health-care workers as a first priority to
protect the essential health infrastructure” [11]. This
recommendation was followed in France and HCW
were the first group to be invited for pandemic vaccina-
tion. The vaccination campaign for this population
began in health care settings (such as hospitals, clinics)
before the opening of mass vaccination centres. Pan-
demic IVC for health care workers was estimated at
around 30%. This result was dramatically lower than the
expected rate (62%) estimated by a study on acceptabil-
ity for A(H1N1) vaccination conducted among HCW
between June and September 2009 [9]. However, ana-
lyses of determinants for IVC showed that being an
health care worker is predictive of a better influenza
vaccination uptake both for seasonal and for pandemic
influenza.
Our study allows to compare at a national level for the
same influenza season, vaccination coverage of seasonal
and pandemic influenza and determinants of these
Table 3 Potential determinants for IVC for seasonal and pandemic influenza, 2009-2010 season (Continued)
Clerical 0.7
(0.5-1.2)
0.8
(0.5-1.3)
ns 1.3
(0.8-2.1)
1.5
(0.8-2.6)
Ns
Retired 6.9
(4.8-9.9)
1.7
(1.1-2.6)
0.02 2.2
(1.3-3.8)
2.0
(1.0-4.0)
0.04
Student 0.4
(0.1-1.9)
0.4
(0.1-2.2)
ns 1.0
(0.2-4.7)
2.3
(0.4-13.0)
Ns
Unemployed 3.1
(1.7-5.7)
1.9
(0.9-3.7)
ns 0.8
(0.3-2.0)
0.7
(0.2-1.9)
Ns
Town size
(Ref. rural)
< 20,000 inhabitants 1.4
(1.0-1.8)
1.4
(1.0-1.9)
0.03 1.0
(0.7-1.5)
-
[20,000; 100 000[ inhabitants 1.4
(1.0-1.9)
1.5
(1.1-2.2)
0.02 1.2
(0.7-1.8)
-
≥ 100 000 inhabitants 1.3
(1.0-1.6)
1.6
(1.2-2.2)
< 0.001 1.3
(0.9-1.9)
-
Paris 0.9
(0.7-1.3)
1.2
(0.8-1.7)
ns 1.4
(0.9-2.2)
-
Free seasonal influenza vaccination
offered (for non at-risk individuals)
3.9
(2.9-5.3)
4.5
(3.2-6.3)
< 0.001 - -
Vaccinated against seasonal influenza - - - 3.5
(2.7-4.6)
7.1
(5.1-10.0)
< 0.001
* for people aged 20-64 years
ns: non significant
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First, it has the usual limitations of retrospective surveys
based on self-report, such as recall bias. Second, a better
participation of persons favourable to vaccination can
not be avoided. Third, our study excluded households
without telephone and those with only mobile-tele-
phones but, this was in part corrected by adjusting sam-
pling weights by age, gender, region and town size.
Because of small numbers in some groups, confidence
intervals were sometimes wide, explaining that results
should be interpreted with caution. We believe, how-
ever, that the impact of these possible biases or limita-
tions is likely to be limited and that the data produced
by this survey contribute significantly to the knowledge
of IVC. The validity of our results was supported by
comparison of estimates produced by other French data
sources. Seasonal IVC estimated by this survey are close
to those of previous seasons produced by the French
general health insurance scheme for at-risk individuals
[12] and for the overall population [13]. Pandemic IVC
estimates are slightly higher than those produced by
official statistics [14] (5.3 millions individuals with at
least one vaccination, around 8.3% of the population)
and those estimated from data produced by the French
general health insurance scheme (5.2 millions, around
8.0% of the population) [15]. The small discrepancies
o b s e r v e dm a yb ee x p l a i n e dby the participation and
reporting biases known to occur in surveys based on
self-reporting, the possibility that some vaccinations
could not be recorded in the general health insurance
vaccination database, or a combination of both
mechanisms.
In most countries where the figures are known, pan-
demic IVC remained low. Data collected by the French
National Assembly investigating committee into the
influenza A(H1N1) vaccination campaign in France
noted uptakes of 10% or less in Germany, England, Bel-
gium, Spain and Italy [16]. Higher IVC than those
observed in France were reported in the United States,
Sweden, Canada, the Netherlands and Japan [17,16]. In
England, uptake was reported to be 37.1% in risk groups
(including pregnant women) [18].
Analysis of determinants of IVC coverage for pan-
demic influenza in comparison with those for seasonal
influenza shows differences and allows drawing some
hypotheses explaining the low vaccination uptakes
observed. Doubts about the severity of the A(H1N1)
2009 epidemic, about the safety and effectiveness of
adjuvanted pandemic vaccines approved through a fast-
track procedure, and the lack of post-marketing surveil-
lance data may explain why people were reluctant to be
vaccinated. In France, as in other countries, these sub-
jects were highly discussed in the media in the autumn
of 2009. In November 2009, only one third of the
French general population considered A(H1N1)2009
influenza illness to be a “severe” or “very severe disease”,
and respondents with a higher perception of severity of
illness and a higher level of concern were significantly
more likely to accept vaccination [9,19]. Results of our
study suggest that a higher level of concern about pan-
demic influenza was observed among children and in
households with the presence of children. The fact that
higher pandemic IVC was observed in households where
the head of the family was a farmer may be related to
the origin of this new virus first reported as of swine
origin.
The mass vaccination centres set up for the pandemic
immunization campaign may also be a key factor
explaining the low vaccination coverage. Contrary to the
pandemic vaccination campaign, the administration of
seasonal influenza vaccines is done by general practi-
tioners (GPs). The role of primary care physicians as a
key factor for reaching high vaccination coverage has
been clearly shown [20,9]. Finally, the choice of a vacci-
nation campaign communication targeting the whole
French population, with few specific messages targeting
at-risk individuals may also explain the low vaccination
coverage found in our study. Uptake of seasonal influ-
enza vaccine has been shown to be a strong predictor of
vaccination intention against pandemic influenza in
French and US populations [21,19]. A positive relation
between seasonal and pandemic vaccine uptake was
shown in our survey: individuals vaccinated against sea-
sonal influenza were more likely to be vaccinated against
pandemic influenza. Offer of a free vaccination has been
shown to be a positive determinant for increasing seaso-
nal influenza uptake, both in the general population and
among health care workers [22]. However cost cannot
explain the low pandemic IVC observed in France
because the pandemic influenza vaccination was offered
free of charge for everyone.
T h er e a s o n sb e h i n dt h eh i g h e rp a n d e m i cI V Cw h e n
the head of the family had a high education level, a
managerial or intermediate occupation could reflect that
these populations are more sensitive to public health
recommendations or perhaps less sensitive to rumors
about the lack of efficacy or safety of the vaccines.
Results of our study allow to draw some hypotheses but
reasons behind reluctance for pandemic vaccination
needs to be further investigated in order to be better
prepared for future health threats that may require mass
immunisation campaigns.
Conclusions
This nationwide study assessed influenza vaccination
uptake for seasonal and pandemic influenza in the
French population. Overall A(H1N1)2009 influenza vac-
cine uptake was low, particularly among at-risk
Vaux et al. BMC Public Health 2011, 11:30
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Page 8 of 9individuals for influenza. The analysis of the determi-
nants of influenza vaccination shows differences
between both vaccination campaigns.
Acknowledgements
We thank all individuals interviewed for the survey and CSA for the
collection of data.
Authors’ contributions
SV, VV, HV, YLS, DLB conceived the study. SV analyzed the results in
consultation with DV, VV, HV, YLS, DLB. SV wrote the draft version and
revisions of the manuscript according to the contribution of DV, YLS, VV, HV,
DLB. All authors read and approved the final version of the manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 13 August 2010 Accepted: 12 January 2011
Published: 12 January 2011
References
1. World Health Organization: Transcript of statement by Margaret Chan,
Director-General of the Word Health Organization: WHO. 2009 [http://
www.who.int/mediacentre/influenzaAH1N1_presstranscript_20090611.pdf],
accessed on April 15, 2010.
2. New influenza A(H1N1) virus infections in France, April - May 2009. Euro
Surveill 2009, 14(21).
3. Levy-Bruhl D, Vaux S: Modified surveillance of influenza A(H1N1)v virus
infections in France. Euro Surveill 2009, 14(29).
4. Vaux S, Brouard C, Fuhrman C, Turbelin C, Cohen JM, Valette M, Enouf V,
Caillère N, George S, Fonteneau L, Gallay A, Nicolau J, Herida M, Gastellu-
Etchegorry M, Mailles A, Belanger F, Cardoso T, Rousset D, Bouscambert-
Duchamp M, Mosnier A, Pelat C, Chiron E, Levy Bruhl D, Saura C:
[Dynamics and impact of the A(H1N1)2009 epidemic in metropolitan
France, 2009-2010]. Dynamique et impact de l’épidémie A(H1N1)2009
en France métropolitaine. Bull Epidemiol Hebd French; 2010, 259-264, 24-
25-26, 22 juin 2010:. [in French].
5. Haut Conseil de la Santé Publique: [Guidance on health priority setting
for the use of pandemic vaccines against A(H1N1)v influenza virus].
Avis: Recommandations sur les priorités sanitaires d’utilisation des
vaccins pandémiques dirigés contre le virus A(H1N1)v. Paris: HCSP; 2009
[http://www.hcsp.fr/docspdf/avisrapports/hcspa20090907_H1N1.pdf],
accessed on May 26, 2010. [in French].
6. Code de la Santé Publique: Article L1121-1. Biomedical research. General
principles. 2010 [http://www.legifrance.gouv.fr/affichCodeArticle.do?
cidTexte=LEGITEXT000006072665& idArticle=LEGIARTI000021942025&
dateTexte=20100429], accessed on November 8.
7. Fuhrman C, Bonmarin I, Paty AC, Duport N, Chiron E, Lucas E, Bitar D,
Mailles A, Herida M, Vaux S, Levy-Bruhl D: Severe hospitalised 2009
pandemic influenza A(H1N1) cases in France, 1 July-15 November 2009.
Euro Surveill 2010, 15(2).
8. Jamieson DJ, Honein MA, Rasmussen SA, Williams JL, Swerdlow DL,
Biggerstaff MS, Lindstrom S, Louie JK, Christ CM, Bohm SR, Fonseca VP,
Ritger KA, Kuhles DJ, Eggers P, Bruce H, Davidson HA, Lutterloh E, Harris ML,
Burke C, Cocoros N, Finelli L, MacFarlane KF, Shu B, Olsen SJ: H1N1 2009
influenza virus infection during pregnancy in the USA. Lancet 2009,
374(9688):451-458.
9. Schwarzinger M, Flicoteaux R, Cortarenoda S, Obadia Y, Moatti JP: Low
acceptability of A/H1N1 pandemic vaccination in French adult
population: did public health policy fuel public dissonance? PLoS One
2010, 5(4):e10199.
10. Miller E, Hoschler K, Hardelid P, Stanford E, Andrews N, Zambon M:
Incidence of 2009 pandemic influenza A H1N1 infection in England: a
cross-sectional serological study. Lancet 2010, 375(9720):1100-1108.
11. World Health Organization: WHO recommendations on pandemic (H1N1)
2009 vaccines. Geneva 2010 [http://www.who.int/csr/disease/swineflu/
notes/h1n1_vaccine_20090713/en/index.html], accessed on June 16.
12. Tuppin P, Samson S, Weill A, Ricordeau P, Allemand H: [Influenza
vaccination coverage in France in 2007-2008: contribution of
vaccination refund data from the general health insurance scheme]. Med
Mal Infect 2009, 39(10):780-788.
13. Lina B, Holm MV, Szucs TD: [Evolution of influenza vaccination coverage
in France from 2001 to 2006]. Med Mal Infect 2008, 38(3):125-132, in
French.
14. CORRUSS: [Influenza A (H1N1. Epidemiological situation and vaccine
coverage. Update 04/05/2010.] Grippe A(H1N1). Situation
épidémiologique et couverture vaccinale. point au 4/5/10. CORRUSS;
2010.
15. Bone A, Guthmann JP, Nicolau J, Levy-Bruhl D: Population and risk group
uptake of H1N1 influenza vaccine in mainland France 2009-2010: results
of a national vaccination campaign. Vaccine 2010, 28(51):8157-8161.
16. Lagarde JC, Door JC: [Report on behalf of the Investigating Committe on
the way in which the influenza A (H1N1) vaccination campaign was
planned, justified and managed.] Rapport fait de la commission
d’enquête sur la manière dont a été programmé, expliquée et gérée la
campagne de vaccination contre la grippe A(H1N1). Assemblée nationale.
Paris 2010 [http://www.assemblee-nationale.fr/13/pdf/rap-enq/r2698.pdf],
accessed on July 30, 2010. [in French].
17. Centers for Disease Control and Prevention: Interim results: state-specific
influenza A (H1N1) 2009 monovalent vaccination coverage - United
States, October 2009-January 2010. MMWR Morb Mortal Wkly Rep 2010,
59(12):363-368.
18. Department of Health: Pandemic H1N1 Vaccine Uptake Figures for
England by SHA and PCT. Departement of Health; 2010 [http://www.dh.
gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@en/@ps/
documents/digitalasset/dh_114212.pdf], accessed on July 30, 2010.
19. Setbon M, Raude J: Factors in vaccination intention against the
pandemic influenza A/H1N1. Eur J Public Health 2010, 20(5):490-4.
20. Maurer J, Uscher-Pines L, Harris KM: Perceived Seriousness of Seasonal
and A(H1N1) Influenzas, Attitudes Toward Vaccination, and Vaccine
Uptake Among U.S. Adults: Does the Source of Information Matter? Prev
Med 2010, 51(2):185-7.
21. Maurer J, Harris KM, Parker A, Lurie N: Does receipt of seasonal influenza
vaccine predict intention to receive novel H1N1 vaccine: evidence from
a nationally representative survey of U.S. adults. Vaccine 2009,
27(42):5732-5734.
22. Vaux S, Noel D, Fonteneau L, Guthmann JP, Levy-Bruhl D: Influenza
vaccination coverage of healthcare workers and residents and their
determinants in nursing homes for elderly people in France: a cross-
sectional survey. BMC Public Health 2010, 10:159.
Pre-publication history
The pre-publication history for this paper can be accessed here:
http://www.biomedcentral.com/1471-2458/11/30/prepub
doi:10.1186/1471-2458-11-30
Cite this article as: Vaux et al.: Influenza vaccination coverage against
seasonal and pandemic influenza and their determinants in France: a
cross-sectional survey. BMC Public Health 2011 11:30.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Vaux et al. BMC Public Health 2011, 11:30
http://www.biomedcentral.com/1471-2458/11/30
Page 9 of 9